In Brief: Sano Corp.
Sano Corp.: Raises an additional $4.5 mil. through exercise of full over-allotment option of 390,000 shares by the company's underwriters of a recent offering, Raymond James & Associates and Vector Securities International. Total proceeds from the offering and over-allotment for the Miramar, Fla.-based transdermal drug delivery firm are approximately $34.4 mil. The company has filed ANDAs for two generic patches and has other proprietary and generic products in various stages of development...
You may also be interested in...
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011
FDA appears headed for a showdown with clinicians and the pharmaceutical industry over the proposed new clinical trial endpoints for acute bacterial skin and skin structure infections, the guidance's approach for justifying a non-inferiority margin and proposed changes in the types of patients that should be enrolled in trials
Specialty drug maker Shire has quietly begun scouting deals with a brand-new $50 million venture fund, the latest of several in-house investment arms to launch with their parent company's pipelines, not profits, as the measure of their worth